The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) recently announced the launch of a Phase II clinical trial called CALIBER, which will test an experimental product called CD24Fc presently being commercialized by...
Institute of Human Virology
Category
Maryland’s Institute of Human Virology Form New Theory to Improve Efficacy & Safety of Immunotherapy Drugs
Researchers from the Institute of Human Virology (IHV), University of Maryland School of Medicine (UMSOM) have proposed a new theory to improve both the efficacy and safety of immunotherapy drugs. The theory calls for a new drug design with an emphasis on side-effect...